349 related articles for article (PubMed ID: 14608114)
41. Growth inhibitory and apoptotic effects of inositol hexaphosphate in transgenic adenocarcinoma of mouse prostate (TRAMP-C1) cells.
Sharma G; Singh RP; Agarwal R
Int J Oncol; 2003 Nov; 23(5):1413-8. PubMed ID: 14532984
[TBL] [Abstract][Full Text] [Related]
42. Mammary tumor inhibition by IP6: a review.
Shamsuddin AM; Vucenik I
Anticancer Res; 1999; 19(5A):3671-4. PubMed ID: 10625937
[TBL] [Abstract][Full Text] [Related]
43. Up-regulation of the tumor suppressor gene p53 and WAF1 gene expression by IP6 in HT-29 human colon carcinoma cell line.
Saied IT; Shamsuddin AM
Anticancer Res; 1998; 18(3A):1479-84. PubMed ID: 9673359
[TBL] [Abstract][Full Text] [Related]
44. Effect of phytic acid and inositol on the proliferation and apoptosis of cells derived from colorectal carcinoma.
Schröterová L; Hasková P; Rudolf E; Cervinka M
Oncol Rep; 2010 Mar; 23(3):787-93. PubMed ID: 20127021
[TBL] [Abstract][Full Text] [Related]
45. Corn-derived carbohydrate inositol hexaphosphate inhibits Barrett's adenocarcinoma growth by pro-apoptotic mechanisms.
McFadden DW; Riggs DR; Jackson BJ; Cunningham C
Oncol Rep; 2008 Feb; 19(2):563-6. PubMed ID: 18202808
[TBL] [Abstract][Full Text] [Related]
46. Inositol polyphosphates contribute to cellular circadian rhythms: Implications for understanding lithium's molecular mechanism.
Wei H; Landgraf D; Wang G; McCarthy MJ
Cell Signal; 2018 Apr; 44():82-91. PubMed ID: 29331582
[TBL] [Abstract][Full Text] [Related]
47. ANTIPROLIFERATIVE EFFECT OF INOSITOL HEXAPHOSPHATE ON HUMAN SKIN MELANOMA CELLS IN VITRO.
Wawszczyk J; Kapral M; Lodowska J; Jesse K; Hollek A; Węglarz L
Acta Pol Pharm; 2015; 72(5):895-900. PubMed ID: 26665395
[TBL] [Abstract][Full Text] [Related]
48. The influence of phytic acid on TNF-alpha and its receptors genes' expression in colon cancer Caco-2 cells.
Cholewa K; Parfiniewicz B; Bednarek I; Swiatkowska L; Jezienicka E; Kierot J; Weglarz L
Acta Pol Pharm; 2008; 65(1):75-9. PubMed ID: 18536177
[TBL] [Abstract][Full Text] [Related]
49. Inositol hexaphosphate (IP6) as an anti-neoplastic and lipid-lowering agent.
Jariwalla RJ
Anticancer Res; 1999; 19(5A):3699-702. PubMed ID: 10625943
[TBL] [Abstract][Full Text] [Related]
50. Inositol hexaphosphate inhibits constitutive activation of NF- kappa B in androgen-independent human prostate carcinoma DU145 cells.
Agarwal C; Dhanalakshmi S; Singh RP; Agarwal R
Anticancer Res; 2003; 23(5A):3855-61. PubMed ID: 14666688
[TBL] [Abstract][Full Text] [Related]
51. The influence of TNF-alpha on concentration of soluble adhesion molecules in cultures of HT-29 cells exposed to inositol hexaphosphate.
Parfiniewicz B; Pendzich J; Kapral M; Bednarek I; Weglarz L
Acta Pol Pharm; 2012; 69(6):1291-7. PubMed ID: 23285692
[TBL] [Abstract][Full Text] [Related]
52. Colloidal Vesicular System of Inositol Hexaphosphate to Counteract DMBA Induced Dysregulation of Markers Pertaining to Cellular Proliferation/Differentiation and Inflammation of Epidermal Layer in Mouse Model.
Arya M; Tiwari P; Tripathi CB; Parashar P; Singh M; Sinha P; Yadav NP; Kaithwas G; Gupta KP; Saraf SA
Mol Pharm; 2017 Mar; 14(3):928-939. PubMed ID: 28169546
[TBL] [Abstract][Full Text] [Related]
53. The effects of inositol hexaphosphate on the inflammatory response in transformed RAW 264.7 macrophages.
Johnson M; Tucci M; Benghuzzi H; Cason Z; Hughes J
Biomed Sci Instrum; 2000; 36():21-6. PubMed ID: 10834203
[TBL] [Abstract][Full Text] [Related]
54. A novel mechanism underlying phytate-mediated biological action-phytate hydrolysates induce intracellular calcium signaling by a Gαq protein-coupled receptor and phospholipase C-dependent mechanism in colorectal cancer cells.
Suzuki T; Nishioka T; Ishizuka S; Hara H
Mol Nutr Food Res; 2010 Jul; 54(7):947-55. PubMed ID: 20146267
[TBL] [Abstract][Full Text] [Related]
55. Inhibition of skin cancer by IP6 in vivo: initiation-promotion model.
Ishikawa T; Nakatsuru Y; Zarkovic M; Shamsuddin AM
Anticancer Res; 1999; 19(5A):3749-52. PubMed ID: 10625952
[TBL] [Abstract][Full Text] [Related]
56. Enhanced killing of androgen-independent prostate cancer cells using inositol hexakisphosphate in combination with proteasome inhibitors.
Diallo JS; Betton B; Parent N; Péant B; Lessard L; Le Page C; Bertrand R; Mes-Masson AM; Saad F
Br J Cancer; 2008 Nov; 99(10):1613-22. PubMed ID: 18941459
[TBL] [Abstract][Full Text] [Related]
57. In vitro regulation of cell growth and angiogenesis by inositol hexaphosphate in bladder cancer.
Kandzari SJ; Riggs D; Jackson B; Luchey A; Oliver C; Zaslau S
Curr Urol; 2013 Feb; 6(4):199-204. PubMed ID: 24917743
[TBL] [Abstract][Full Text] [Related]
58. Inositol hexaphosphate inhibits tumor growth, vascularity, and metabolism in TRAMP mice: a multiparametric magnetic resonance study.
Raina K; Ravichandran K; Rajamanickam S; Huber KM; Serkova NJ; Agarwal R
Cancer Prev Res (Phila); 2013 Jan; 6(1):40-50. PubMed ID: 23213071
[TBL] [Abstract][Full Text] [Related]
59. Inositol hexaphosphate (IP6) inhibits key events of cancer metastasis: II. Effects on integrins and focal adhesions.
Tantivejkul K; Vucenik I; Shamsuddin AM
Anticancer Res; 2003; 23(5A):3681-9. PubMed ID: 14666664
[TBL] [Abstract][Full Text] [Related]
60. Molecular mechanism of inositol hexaphosphate-mediated apoptosis in human malignant glioblastoma T98G cells.
Karmakar S; Banik NL; Ray SK
Neurochem Res; 2007 Dec; 32(12):2094-102. PubMed ID: 17616815
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
